fentaNYL 500 mcg/100 mL, Bupivacaine HCl 0.075% in 0.9% Sodium Chloride 100 mL Injection (fentaNY...

FDA Recall #D-0401-2024 — Class II — November 9, 2023

Recall #D-0401-2024 Date: November 9, 2023 Classification: Class II Status: Terminated

Product Description

fentaNYL 500 mcg/100 mL, Bupivacaine HCl 0.075% in 0.9% Sodium Chloride 100 mL Injection (fentaNYL Concentration = 5 mcg/mL), EPIDURAL USE ONLY, 100 mL Yellow CADD Cassette, Rx only, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT 06095, NDC 70004-0251-64, Bar Code 70004025164

Reason for Recall

Lack of Assurance of Sterility

Recalling Firm

SCA Pharmaceuticals, LLC — Windsor, CT

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

130 cassettes

Distribution

Nationwide in the USA

Code Information

Lot #: 1223048722, Exp 11/29/23; 1223049096, Exp 12/15/23

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated